ANDA 87702, held by Hikma Pharmaceuticals. Dexamethasone Sodium Phosphate.
As of Nov 21, 2026, ANDA 87702 (Dexamethasone Sodium Phosphate), held by Hikma Pharmaceuticals, was first approved by FDA on Sep 7, 1982, with 28 approved supplements and 0 published complete response letters.
INDICATIONS A. Intravenous or intramuscular administration. When oral therapy is not feasible and the strength, dosage form, and route of administration of the drug reasonably lend the preparation to the treatment of the condition, those products labeled for intravenous or intramuscular use are indicated as follows: 1.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 7, 1982 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Dexamethasone Sodium PhosphateEQ 10MG PHOSPHATE/ML · injectable;injection | Dexamethasone Sodium Phosphate | Rx |
| Jun 5, 2024 | Supplement 50Labeling · Standard review | Approved | None posted |
| Jul 29, 2020 | Supplement 41Labeling · Standard review | Approved | None posted |
| Jul 29, 2020 | Supplement 39Labeling · Standard review | Approved | None posted |
| Jul 3, 2014 | Supplement 36Labeling · Standard review | Approved | None posted |
| Jan 7, 2003 | Supplement 29Manufacturing | Approved | None posted |
| Sep 5, 2001 | Supplement 28Manufacturing | Approved | None posted |
| Jul 11, 2000 | Supplement 27Manufacturing | Approved | None posted |
| Sep 7, 1999 | Supplement 26Manufacturing | Approved | None posted |
| Dec 1, 1998 | Supplement 25Manufacturing | Approved | None posted |
| Jun 12, 1998 | Supplement 22Manufacturing | Approved | None posted |
| May 7, 1998 | Supplement 21Manufacturing | Approved | None posted |
| Feb 15, 1995 | Supplement 20Labeling | Approved | None posted |
| Apr 19, 1994 | Supplement 19Manufacturing | Approved | None posted |
| Jan 27, 1994 | Supplement 18Labeling | Approved | None posted |
| Jan 14, 1992 | Supplement 14Manufacturing | Approved | None posted |
| Oct 28, 1991 | Supplement 17Labeling | Approved | None posted |
| Jun 12, 1991 | Supplement 16Labeling | Approved | None posted |
| Sep 21, 1989 | Supplement 13Labeling | Approved | None posted |
| May 26, 1989 | Supplement 12Labeling | Approved | None posted |
| May 26, 1989 | Supplement 11Labeling | Approved | None posted |
| Feb 7, 1989 | Supplement 10Labeling | Approved | None posted |
| Mar 21, 1988 | Supplement 6Manufacturing | Approved | None posted |
| Mar 21, 1988 | Supplement 5Manufacturing | Approved | None posted |
| Mar 21, 1988 | Supplement 4Manufacturing | Approved | None posted |
| Apr 2, 1987 | Supplement 9Manufacturing | Approved | None posted |
| Nov 27, 1984 | Supplement 3Manufacturing | Approved | None posted |
| Jan 31, 1983 | Supplement 1Manufacturing | Approved | None posted |
| Jan 31, 1983 | Supplement 2Manufacturing | Approved | None posted |
| Sep 7, 1982 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters